newsfilter
← Latest News
GlobeNewswire·

Flexion Therapeutics to Advance Investigational Gene Therapy FX201 into High Dose Cohort of Phase 1 Clinical Trial in Knee Osteoarthritis and Expand Low and Mid Dose Treatment Groups

First-in-human single ascending dose trial advances to high dose cohort following positive Data Monitoring Committee review of mid dose safety dataCompany to expand FX201 low dose and mid dose cohorts...